ElevateBio Announces AlloVir As First Spoke In Its Cell And Gene Therapy Hub

 
• By Mandy Jackson

ElevateBio revealed the first company to hitch up with its newly established centralized cell and gene therapy development, manufacturing and commercial capabilities – AlloVir, formerly ViraCyte, which is developing T-cell therapies to treat viruses in immunocompromised patients.

AlloVir Viralym M test tube
AlloVir's lead product candidate is allogeneic T-cell therapy Viralym-M • Source: AlloVir

More from Financing

More from Business